Swissmedic Guidance on Injectable Products for Wrinkle Treatment
Healthcare professionals must report all serious incidents involving injectable devices to Swissmedic as outlined in the new guidance.
Tag archive
Healthcare professionals must report all serious incidents involving injectable devices to Swissmedic as outlined in the new guidance.
Sponsors must align their products with the updated safety and formulation requirements for permissible ingredients as per the new determination.
MAHs should prepare for enhanced regulatory collaboration, including potential joint oversight activities and reduced market friction between the UK and US due to closer alignment in regulatory decisions.
Review the consultation document and consider submitting feedback by 2026-07-31. Monitor for final regulatory changes affecting radiopharmaceutical safety monitoring and compliance.
Subscribe to impact-first pharmacovigilance updates. Select every role you want in your digest.
Digest roles: QPPV. Work email only